Madrigal Pharmaceuticals, Inc. Financials

Market Capitalization $7.42 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-16.42
Forward PE	-24.37
Price to Sales TTM	$96.58
Price to Book MRQ	$9.54
Enterprise to Revenue	85.13
Enterprise to EBITDA	-11.95

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	0.00%
Operating Margin	-187.06%
Return on Assets TTM	-52.25%
Return on Equity TTM	-129.76%

Income Statement

Revenue TTM	$76,813,000
Revenue per Share TTM	$3.71
Quarterly Revenue Growth	324.75%
Gross Profit TTM	$74,025,000
EBITDA	$-547,180,032
Net Income to Common TTM	$-518,670,016
Diluted EPS TTM	$-25.03
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$998,627,008
Total Cash per Share MRQ	$45.79
Total Debt MRQ	$
Total Debt to Equity MRQ	15.33
Current Ratio MRQ	5.98
Book Value per Share MRQ	$35.64

Cash Flow

Operating Cash Flow TTM	$-431,019,008
Levered Free Cash Flow TTM	$-263,114,752

MDGL Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	21,810,400
Float Shares	10,733,556
Avg 10 Volume	608,790
Avg 30 Volume	None
Shares Short	4,106,529
Short Ratio	13.08
Short % of Shares	27.02%
% Held by Insiders	8.55%
% Held by Institutions	105.95%

Stock Price Summary

Beta	-0.47
Fifty Two Week Low	$168.25
Fifty Two Week High	$368.29
Fifty Two Week Change	30.83%
Day 50 MA	$314.96
Day 200 MA	$262.41

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2016-07-25
Ex Dividend Date
Last Split Factor
Last Split Date	2016-07-25